According to a recent study, guselkumab does not increase cancer risk in psoriasis (PsO) patients compared to general and psoriasis populations.
top of page
it's where dermatology lives
bottom of page
According to a recent study, guselkumab does not increase cancer risk in psoriasis (PsO) patients compared to general and psoriasis populations.
Comentários